Redhill Biopharma Stock Forecast - Daily Balance Of Power

RDHL Stock  USD 6.78  0.04  0.59%   
Redhill Stock Forecast is based on your current time horizon. Although Redhill Biopharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Redhill Biopharma's systematic risk associated with finding meaningful patterns of Redhill Biopharma fundamentals over time.
  
At this time, Redhill Biopharma's Fixed Asset Turnover is quite stable compared to the past year. Asset Turnover is expected to rise to 0.30 this year, although the value of Inventory Turnover will most likely fall to 0.75. . Common Stock Shares Outstanding is expected to rise to about 6.8 M this year, although the value of Net Loss is projected to rise to (83.6 M).
On September 30, 2024 Redhill Biopharma had Daily Balance Of Power of 0.2444. Balance of Power indicator (or BOP) measures the strength of Redhill Biopharma market sensitivity to bulls and bears. It estimates the ability of Redhill Biopharma buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Redhill Biopharma Balance of Power indicator one can determine a trend of the price direction.
Check Redhill Biopharma VolatilityBacktest Redhill BiopharmaTrend Details  

Redhill Biopharma Trading Date Momentum

On October 01 2024 Redhill Biopharma was traded for  8.30  at the closing time. The top price for the day was 9.05  and the lowest listed price was  8.30 . The trading volume for the day was 28.7 K. The trading history from October 1, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 5.03% . The trading delta at closing time against the current closing price is 6.64% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Redhill Biopharma to competition

Other Forecasting Options for Redhill Biopharma

For every potential investor in Redhill, whether a beginner or expert, Redhill Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Redhill Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Redhill. Basic forecasting techniques help filter out the noise by identifying Redhill Biopharma's price trends.

View Redhill Biopharma Related Equities

 Risk & Return  Correlation

Redhill Biopharma Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Redhill Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Redhill Biopharma's current price.

Redhill Biopharma Market Strength Events

Market strength indicators help investors to evaluate how Redhill Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Redhill Biopharma shares will generate the highest return on investment. By undertsting and applying Redhill Biopharma stock market strength indicators, traders can identify Redhill Biopharma entry and exit signals to maximize returns.

Redhill Biopharma Risk Indicators

The analysis of Redhill Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Redhill Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting redhill stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Redhill Biopharma is a strong investment it is important to analyze Redhill Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Redhill Biopharma's future performance. For an informed investment choice regarding Redhill Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Redhill Biopharma to cross-verify your projections.
For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. If investors know Redhill will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Redhill Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(302.63)
Revenue Per Share
4.733
Quarterly Revenue Growth
(0.28)
Return On Assets
(0.45)
Return On Equity
(17.09)
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Redhill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Redhill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Redhill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.